These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9873625)

  • 1. Structure-activity studies related to ABT-594, a potent nonopioid analgesic agent: effect of pyridine and azetidine ring substitutions on nicotinic acetylcholine receptor binding affinity and analgesic activity in mice.
    Holladay MW; Bai H; Li Y; Lin NH; Daanen JF; Ryther KB; Wasicak JT; Kincaid JF; He Y; Hettinger AM; Huang P; Anderson DJ; Bannon AW; Buckley MJ; Campbell JE; Donnelly-Roberts DL; Gunther KL; Kim DJ; Kuntzweiler TA; Sullivan JP; Decker MW; Arneric SP
    Bioorg Med Chem Lett; 1998 Oct; 8(19):2797-802. PubMed ID: 9873625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
    Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
    J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors.
    Holladay MW; Wasicak JT; Lin NH; He Y; Ryther KB; Bannon AW; Buckley MJ; Kim DJ; Decker MW; Anderson DJ; Campbell JE; Kuntzweiler TA; Donnelly-Roberts DL; Piattoni-Kaplan M; Briggs CA; Williams M; Arneric SP
    J Med Chem; 1998 Feb; 41(4):407-12. PubMed ID: 9484491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New nonopioid painkiller shows promise in animal tests.
    Strauss E
    Science; 1998 Jan; 279(5347):32-3. PubMed ID: 9441405
    [No Abstract]   [Full Text] [Related]  

  • 5. Interaction of the nicotinic agonist (R,S)-3-pyridyl-1-methyl-2-(3-pyridyl)-azetidine (MPA) with nicotinic acetylcholine receptor subtypes expressed in cell lines and rat cortex.
    Zhang X; Gong ZH; Fasth KJ; Långström B; Nordberg A
    Neurochem Int; 1998; 32(5-6):435-41. PubMed ID: 9676742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors.
    Bannon AW; Decker MW; Holladay MW; Curzon P; Donnelly-Roberts D; Puttfarcken PS; Bitner RS; Diaz A; Dickenson AH; Porsolt RD; Williams M; Arneric SP
    Science; 1998 Jan; 279(5347):77-81. PubMed ID: 9417028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Advances in the research on nicotinic acetylcholine receptors agonists].
    Chen JH; Bai DL
    Yao Xue Xue Bao; 2002 Apr; 37(4):309-15. PubMed ID: 12579830
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis and characterization of binding of 5-[76Br]bromo-3-[[2(S)-azetidinyl]methoxy]pyridine, a novel nicotinic acetylcholine receptor ligand, in rat brain.
    Sihver W; Fasth KJ; Horti AG; Koren AO; Bergström M; Lu L; Hagberg G; Lundqvist H; Dannals RF; London ED; Nordberg A; Långström B
    J Neurochem; 1999 Sep; 73(3):1264-72. PubMed ID: 10461920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure-activity data of some new epibatidine analogues.
    Seerden JP; Tulp MT; Scheeren HW; Kruse CG
    Bioorg Med Chem; 1998 Nov; 6(11):2103-10. PubMed ID: 9881100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analgesic profile of the nicotinic acetylcholine receptor agonists, (+)-epibatidine and ABT-594 in models of persistent inflammatory and neuropathic pain.
    Kesingland AC; Gentry CT; Panesar MS; Bowes MA; Vernier JM; Cube R; Walker K; Urban L
    Pain; 2000 May; 86(1-2):113-8. PubMed ID: 10779668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-(2,5-Dihydro-1H-pyrrol-2-ylmethoxy)pyridines: synthesis and analgesic activity.
    Baraznenok IL; Jonsson E; Claesson A
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1637-40. PubMed ID: 15745813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epibatidine is a nicotinic analgesic.
    Qian C; Li T; Shen TY; Libertine-Garahan L; Eckman J; Biftu T; Ip S
    Eur J Pharmacol; 1993 Dec; 250(3):R13-4. PubMed ID: 8112391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antinociceptive effects of the novel neuronal nicotinic acetylcholine receptor agonist, ABT-594, in mice.
    Decker MW; Bannon AW; Buckley MJ; Kim DJ; Holladay MW; Ryther KB; Lin NH; Wasicak JT; Williams M; Arneric SP
    Eur J Pharmacol; 1998 Apr; 346(1):23-33. PubMed ID: 9617748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors.
    Abreo MA; Lin NH; Garvey DS; Gunn DE; Hettinger AM; Wasicak JT; Pavlik PA; Martin YC; Donnelly-roberts DL; Anderson DJ; Sullivan JP; Williams M; Arneric SP; Holladay MW
    J Med Chem; 1996 Feb; 39(4):817-25. PubMed ID: 8632405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2',3'-disubstituted 5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes: epibatidine analogues.
    Carroll FI; Lee JR; Navarro HA; Ma W; Brieaddy LE; Abraham P; Damaj MI; Martin BR
    J Med Chem; 2002 Oct; 45(21):4755-61. PubMed ID: 12361403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity studies and analgesic efficacy of N-(3-pyridinyl)-bridged bicyclic diamines, exceptionally potent agonists at nicotinic acetylcholine receptors.
    Bunnelle WH; Daanen JF; Ryther KB; Schrimpf MR; Dart MJ; Gelain A; Meyer MD; Frost JM; Anderson DJ; Buckley M; Curzon P; Cao YJ; Puttfarcken P; Searle X; Ji J; Putman CB; Surowy C; Toma L; Barlocco D
    J Med Chem; 2007 Jul; 50(15):3627-44. PubMed ID: 17585748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective ligand behaviors provide new insights into agonist activation of nicotinic acetylcholine receptors.
    Marotta CB; Rreza I; Lester HA; Dougherty DA
    ACS Chem Biol; 2014 May; 9(5):1153-9. PubMed ID: 24564429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-, 5-, and 6-Halo-3-(2(S)-azetidinylmethoxy)pyridines: synthesis, affinity for nicotinic acetylcholine receptors, and molecular modeling.
    Koren AO; Horti AG; Mukhin AG; Gündisch D; Kimes AS; Dannals RF; London ED
    J Med Chem; 1998 Sep; 41(19):3690-8. PubMed ID: 9733494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of two fluoro analogues of the nicotinic acetylcholine receptor agonist UB-165.
    Sutherland A; Gallagher T; Sharples CG; Wonnacott S
    J Org Chem; 2003 Mar; 68(6):2475-8. PubMed ID: 12636420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitrogen substitution modifies the activity of cytisine on neuronal nicotinic receptor subtypes.
    Carbonnelle E; Sparatore F; Canu-Boido C; Salvagno C; Baldani-Guerra B; Terstappen G; Zwart R; Vijverberg H; Clementi F; Gotti C
    Eur J Pharmacol; 2003 Jun; 471(2):85-96. PubMed ID: 12818695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.